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Abstract
Previous work has shown that the effect of opioid-receptor blockade on memory modulation is
critically dependent upon the intensity of stress. The current study determined the effect of
adrenergic-receptor blockade on memory modulation under varied levels of stress and then
compared the effect of adrenergic-receptor blockade under intense stress to that of a) opioid-
receptor blockade and b) concurrent opioid- and adrenergic-receptor blockade. In the first
experiment, the β-adrenergic-receptor blocker propranolol impaired retention in the passive-
avoidance procedure when administered immediately after exposure to intense stress (passive-
avoidance training followed by swim stress) but not mild stress (passive-avoidance training alone).
In the second experiment, while separate administration of either propranolol or the opioid-
receptor blocker naloxone immediately after exposure to intense stress impaired retention, the
combined administration of propranolol and naloxone failed to do so. These findings demonstrate
that the effect of β-adrenergic-receptor blockade or opioid-receptor blockade on memory
modulation in the passive-avoidance procedure is dependent upon the intensity of stress, and
suggest that concurrent inactivation of endogenous adrenergic- and opioid-based memory
modulation systems under stressful conditions is protective of memory.
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1. Introduction
Evidence that an adrenergic-mediated system modulates memory under stressful conditions
comes primarily from studies in which adrenergic agonists, administered shortly after
passive-avoidance training, enhance retention (Ferry et al., 1999; Ferry and McGaugh, 2008;
Liang et al., 1986, 1990). Less consistent are the results of studies investigating the effect on
memory modulation of adrenergic blockers; for example, the β-adrenergic antagonist
propranolol, administered systemically shortly after training, impairs retention in a spatial
water maze (Cahill et al., 2000) but fails to impair retention in a passive-avoidance
procedure (Decker et al., 1990; McGaugh, 1989; Saha et al., 1991). Immersion in water that
accompanies spatial water maze learning, however, is extremely stressful and markedly
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activates the endogenous adrenergic system (Cahill et al., 2000; Mabry et al., 1995).
Consequently, a possible explanation for these conflicting results is that the intensity of
stress from immersion in water (that accompanies spatial water maze learning) is greater
than that of stress from mild footshock (used in passive-avoidance training), suggesting that
the effectiveness of β-adrenergic receptor blockade in impairing retention depends on the
level of stress (and thus the degree of stress-induced adrenergic system activation) that
accompanies its administration. This hypothesis was tested in the first experiment by
determining if propranolol impairs retention in the passive-avoidance procedure when
animals are exposed to an additional stressor (forced swim) known to activate memory
modulation systems, including the endogenous adrenergic system (Gotoh et al., 1998;
Jordan et al., 1994), subsequent to passive-avoidance training.
A similar hypothesis has previously been tested regarding the effect on retention of blockade
of another stress-related memory-modulation system, the opioid system (Schneider et al.,
2009). The findings indicated that the effectiveness of opioid-receptor blockade in impairing
retention depended on intensity of stress. Consequently, in the second experiment, the effect
of pharmacological blockade of the adrenergic system on retention under highly stressful
conditions was compared to that of blockade of the opioid system, while the potential
interaction between the two memory modulation systems was investigated through
concurrent β-adrenergic receptor and opioid-receptor blockade.
2. Material and methods
2.1. Subjects
The subjects (n = 69) were male Long-Evans hooded rats weighing 240–280 g at the start of
the experiment. The rats were housed two to a cage with access to food and water ad
libitum. The colony room was maintained at 20 °C and was illuminated on a 12-h light–dark
cycle (lights on at 9:00 a.m.). All experiments were conducted between 10:00 a.m. and
12:00 p.m. The experimental protocol was approved by Swarthmore College's Institutional
Animal Care and Use Committee and was in compliance with the National Research Council
Guide for the Care and Use of Laboratory Animals.
2.2. Apparatus
The rats were trained in a standard trough-shaped passive-avoidance apparatus that consisted
of a small lighted compartment (20 W × 28 H × 18 L cm at the top; 8 W × 28 H × 18 L cm
at the base), illuminated by a 95-W bulb, connected to a larger dark compartment (20W × 28
H × 42 L cm at the top; 8W × 28 H × 42 L cm at the base). A manually operated sliding
door separated the two compartments. The top of each compartment was hinged and the
floor of each compartment was made of stainless steel plates. A constant-current Lafayette
Master Shocker (Model 2400SS; Lafayette, IN) was connected to the floor of the large
compartment. The apparatus was located in a quiet, dimly illuminated room.
2.3. Drug administration and drug doses
The rats were injected intraperitoneally with vehicle (0.9% saline, 2 ml/kg), the β-adrenergic
antagonist dl-propranolol hydrochloride (10 mg/kg, 2 ml/kg, Sigma Chemical), the opioid
antagonist naloxone hydrochloride (3 mg/kg, 2 ml/kg, Sigma Chemical) or a mixture of
propranolol (10 mg/kg) and naloxone (3 mg/kg) in a 2 ml/kg injection volume. The dose of
propranolol chosen was similar to doses that have previously been shown to be effective in
adrenergic studies on memory modulation (Cahill et al., 2000; Przybyslawski et al., 1999).
The dose of naloxone has been used in previous passive-avoidance studies including a dose–
response study (Schneider et al., 2006) using the procedures employed in the present study
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to produce both enhancement and impairment of retention under mild and intense stress,
respectively (McGaugh et al., 1988; Schneider et al., 2009).
2.4. Forced swim procedure
The forced swim procedure (15 min in duration) was administered in a quiet, dimly lit room
and consisted of placing rats in a cylindrical tank (46-cm tall × 20-cm diameter) with water
(~22 °C) filled to a depth of 30 cm (Porsolt et al., 1978; Schneider et al., 2009). The water
depth of 30 cm forced the rats to swim or float without their tails touching the bottom of the
tank.
The use of a compound stressor (i.e., foot-shock from passive-avoidance training followed
by forced swim) to augment the intensity of stress exposure has been validated in previous
neurochemical studies using activation of the hypothalamo-pituitary-adrenal (HPA) axis as a
physiological index of stress intensity. In these studies, not only has swim stress been shown
to elevate levels of plasma corticosterone (Kirby et al., 1995) and alter norepinephrine (NE)
and opioid (dynorphin) levels in limbic nuclei, including the amygdala (Gotoh et al., 1998;
Jordan et al., 1994; Land et al., 2008), but the HPA response to swim stress has been shown
to be augmented by prior exposure to shock (Christianson et al., 2003). Thus, exposure to
forced swimming – with or without exposure to shock – not only meets the criteria of a
stressor but produces neurochemical effects (particularly with respect to adrenergic and
opioid action) consistent with a potential modulator of retention under highly stressful
conditions.
2.5. Experimental procedure
Two experiments were conducted. The timeline for each experiment was as follows: rats
underwent passive-avoidance training, in which they received a single foot-shock for
stepping from a lighted to dark compartment, followed immediately by the experimental
treatment (see below); 24 h later, a retention test was administered.
2.5.1. Passive-avoidance training—The training procedure consisted of the following:
each rat was placed in the lighted compartment facing away from the sliding door. After 15 s
the door was raised, the animal was allowed to step into the dark compartment, the door was
lowered and shock (0.5 mA, 0.5 s) was delivered to the floor of the compartment. The
animal remained in the dark compartment for 15 s and was then removed and immediately
administered the experimental treatment. After each animal completed the trial the
apparatus was cleaned.
2.5.2. Experimental treatment—In the first experiment, immediately after training, the
animals were randomly assigned to one of two groups: swim and no swim. Animals in the
swim group were exposed to forced swim stress (15 min in duration); animals in the no
swim group were, in lieu of exposure to forced swim, placed in a quiet, dimly lit room (15
min in duration). Immediately thereafter each group was divided into two subgroups and
was administered either the adrenergic blocker propranolol (Pro) or the vehicle yielding the
following 4 groups: No Swim-Vehicle, No Swim-Pro, Swim-Vehicle and Swim-Pro.
In the second experiment, immediately after training, all animals were exposed to forced
swim (15 min in duration) and then were randomly assigned to one of four groups – Swim-
Vehicle, Swim-Pro, Swim-Nal and Swim-Pro + Nal – that received vehicle, propranolol
(Pro), naloxone (Nal), or a combination of propranolol and naloxone, respectively.
2.5.3. Testing—The next day, animals received a retention test (identical to the training
trial except shock was omitted and the experimental treatment was not administered) in
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which step-through latencies (STLs) served as the measure of retention (i.e., as STLs
increased, retention was taken to increase). If STLs reached 600 s, the trial was terminated.
2.6. Statistical analysis
Data were analyzed with one-way analyses of variance which, if statistically significant,
were followed by protected-t multiple comparisons tests. P values (two-tailed) of less than
or equal to .05 were taken as statistically significant.
3. Results
The results of the first experiment, as shown in Fig. 1, indicate that propranolol administered
immediately after exposure to the compound stressor (that is, foot-shock from the training
procedure followed by forced swim) impaired retention: mean STLs in the Swim-Pro group
(97.0 ± 50.8) were markedly lower than mean STLs in the Swim-Vehicle group (342.6 ±
96.1) (t(14) = 2.41, p<0.05). On the other hand, propranolol administered in the absence of
forced swim (i.e., when the stressor was foot-shock alone from the training procedure) did
not impair retention: the difference in mean STLs between the No Swim-Pro group (334.8 ±
83.1) and the No Swim-Vehicle group (368.2 ± 76.4) did not reach statistical significance
(t(15) = 0.29, p = 0.77). The finding that propranolol impaired retention only when
administered after an intense stressor (specifically, after the combined stressor of foot-shock
from passive-avoidance training followed by exposure to forced swim) is consistent with the
hypothesis that propranolol's effectiveness in producing impairment of retention in the
passive-avoidance task depends on the level of stress that accompanies its administration.
It can also be seen in Fig. 1 that forced swim per se, in the absence of propranolol, had no
effect on retention: mean STLs in the Swim-Vehicle (342.6 ± 96.1) and No Swim-Vehicle
(368.2 ± 76.4) groups did not differ significantly (t(13) = 0.21, p = 0.84). The finding that
forced swim had no effect on retention unless it was accompanied by adrenergic-receptor
blockade suggests a “protective” function for the (unblocked) adrenergic-based modulatory
system: when not blocked by propranolol, the adrenergic system prevents impairment of
retention under conditions of intense stress.
The results of the second experiment, as shown in Fig. 2, reveal that separate administration
of propranolol or naloxone immediately after exposure to the compound stressor (foot-shock
followed by forced swim) impaired retention in the passive-avoidance procedure. In
contrast, the combined administration of propranolol and naloxone produced no such
impairment of retention. Specifically, mean STLs in the Swim-Nal (69.7 ± 38.5) and Swim-
Pro group (83.1 ± 37.3) were significantly lower (t(16) = 3.56, p<0.01 and t(16) = 3.45,
p<0.01, respectively) than mean STLs in the Swim-Vehicle group (349.2 ± 72.9). In contrast,
mean STLs in the Swim-Pro + Nal group (305.0 ± 77.1) did not differ significantly (t(14) =
0.42, p = 0.68) from the Swim-Vehicle group (349.2 ± 72.9) but did differ (t(16) = 2.90,
p<0.05 and t(16) = 2.75, p<0.05, respectively) from mean STLs in the Swim-Nal (69.7 ±
38.5) and the Swim-Pro groups (83.1 ± 37.3).
4. Discussion
The present findings demonstrate that a) β-adrenergic receptor blockade impairs retention
when occurring immediately after intense, but not mild, stress in the passive-avoidance
procedure, suggesting the presence of a protective, stress-dependent adrenergic-based
modulation system, b) opioid-receptor blockade impairs retention when occurring
immediately after intense stress in the passive-avoidance procedure, suggesting the presence
of a protective, stress-dependent opioid-based modulation system, and c) simultaneous
blockade of β-adrenergic and opioid receptors prevents impairment of retention when
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occurring immediately after exposure to intense stress in the passive-avoidance procedure,
suggesting a non-additive interaction between the two modulation systems. Thus, these
findings, taken together with earlier work (Schneider et al., 2009), not only indicate that the
ability of β-adrenergic or opioid-receptor blockade to impair retention is critically dependent
upon the intensity of stress, but also that the pharmacologically inactivated adrenergic-based
and opioid-based memory-modulation systems interact to prevent impairment of retention.
One possible explanation for these results that is consistent with the literature is based on
evidence indicating that stress affects memory via the combined and opposing action of
inhibitory-opioid and excitatory-adrenergic modulation systems in brain sites such as the
amygdala (Buffalari and Grace, 2007; Gallagher and Kapp, 1978; Gean et al., 1992; Huang
et al., 1996; McIntyre and Wong, 1986). Accordingly in the present study, by singling out
either the inhibitory-opioid or excitatory-adrenergic system alone through pharmacological
blockade of the other, the unblocked system acts unopposed to impair retention: In the
presence of adrenergic-receptor blockade, the unblocked inhibitory-opioid system “over-
suppresses” brain sites (e.g., the amygdala) modulating memory; in the presence of opioid-
receptor blockade, the unblocked excitatory-adrenergic system “over-activates” these brain
sites. This would account for the impairment of retention produced by the separate
administration of propranolol or naloxone. In contrast, neither over-suppression nor over-
activation of modulation sites – and therefore no impairment of retention – should occur
when a) both the inhibitory-opioid and excitatory-adrenergic systems are concurrently
inactivated, or b) both systems are actively working in opposition to one another. These
effects (or, more accurately, the lack thereof) on retention are precisely what occurred in the
present study: the combined administration of propranolol and naloxone (perhaps by
concurrently blocking both the excitatory-adrenergic and inhibitory-opioid modulation
systems) failed to impair retention, as did the “administration” of swim-stress alone (perhaps
by simultaneously activating the opposing modulation systems and thereby preventing over-
excitation or over-suppression of brain sites modulating memory).
Combined and opposing action of inhibitory-opioid and excitatory-adrenergic modulation
systems can also explain the enhancement of retention produced by naloxone under mildly
stressful conditions (mild shock from passive-avoidance training in the absence of swim-
stress) seen in previous studies (Introini-Collison et al., 1989; McGaugh et al., 1988;
Schneider et al., 2009). Specifically, the unblocked, endogenous opioid-based system,
activated by mild stress, serves to limit enhancement of retention by opposing the
simultaneous activation (as opposed to over-activation) of the excitatory adrenergic-based
system. Accordingly, blockade of the inhibitory opioid-based system by naloxone under
mildly stressful conditions enhances retention by reducing opposition to the excitatory
adrenergic-based (facilitating) system. In this regard, previous studies have not only shown
a) enhancement of retention by naloxone under mildly stressful conditions, but also,
paralleling the results of the present study, b) amelioration of this enhancement (as opposed
to impairment under intense stress in the present study) through concurrent blockade of the
adrenergic-based system via intra-amygdala infusion of propranolol (Introini-Collison et al.,
1989; McGaugh et al., 1988).
Given the ability of forced swim to reduce core body temperature (Porsolt et al., 1979), one
might propose that the effects of propranolol and naloxone on retention were influenced by
hypothermia. Indeed, previous studies have shown that forced swim (15-min) in 20–25 °C
water can reduce rat body temperature by 5–10 °C (Drugan et al., 2005; Porsolt et al., 1979);
this magnitude of hypothermia can impair clearance rates of a number of drugs (van den
Broek et al., 2010), including propranolol (McAllister and Tan, 1980), owing to decreased
activity of liver enzymes.
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Although impairment of drug clearance may have occurred in the present study, it did not
appear to have a significant behavioral effect: the effect of the drugs in animals exposed to
forced swim was not amplified to a level expected were drug clearance significantly
impaired, that is, were drug potency significantly augmented by hypothermia. For example,
administration of propranolol (10 mg/kg) after forced swim did not produce the toxic effects
(e.g., sedation and writhing) typically associated with administration of higher doses of the
agent (15 mg/kg) seen in previous studies in the absence of forced swim (Pontecorvo et al.,
1991). Moreover, when administered separately at doses twice as high as those shown in the
present study to impair retention after forced swim, propranolol and naloxone fail to impair
retention in the absence of forced swim (Beatty and Rush, 1983; Messing et al., 1979). Thus,
it seems reasonable to conclude that the behavioral effects observed in the present study
were not influenced to an appreciable extent by hypothermia-augmented drug potency.
In view of the relative importance given to the role of the adrenergic-based system in
mediating the effect of stress on memory modulation (Galvez et al., 1996; Quirarte et al.,
1998), it is perhaps surprising that only one other study has demonstrated an impairing effect
of systemic blockade of the adrenergic system on retention in the passive-avoidance
procedure (Przybyslawski et al., 1999). One reason – the one that distinguishes the present
study – may be methodology: the combination of passive-avoidance training and forced
swim.
On the other hand, although the impairing effect of systemically administered propranolol in
the passive-avoidance procedure is relatively new, the finding of impairment of retention by
propranolol in general is not. Specifically, in addition to impairing retention when
administered systemically in the present study or the water maze (Cahill et al., 2000), local
infusion of propranolol into the amygdala impairs retention both in the passive-avoidance
procedure (Gallagher et al., 1977; Lennartz et al., 1996) as well as an object learning task
(Roozendaal et al., 2008). These findings, particularly with regard to object learning wherein
the animals are not under intense stress prior to administration of the drug, suggest that
propranolol's effectiveness in producing impairment depends not only on the level of stress
(as shown in the present study), but also on the mode of administration (as shown in the
local administration studies).
One brain site potentially mediating the effect of blockade of the adrenergic and/or opioid
modulation systems on retention in the present study, as suggested by the local infusion
studies, is the amygdala. The amygdala is rich in all major subtypes of opioid (Mansour et
al., 1994) and adrenergic (U'Prichard et al., 1980) receptors, and opioid (dynorphin) and NE
release in the amygdala are increased by stress (Galvez et al., 1996; Hatfield et al., 1999;
Land et al., 2008). Further, whereas β-adrenergic agonists increase both neuronal activity
(Buffalari and Grace, 2007; McIntyre and Wong, 1986) and excitatory neurotransmission in
the amygdala (Ferry et al., 1997; Gean et al., 1992; Huang et al., 1996) and, at all but the
highest doses [owing to an inverted-U dose–response function (Gold, 2006)], enhance
retention in the passive-avoidance procedure, opioid agonists decrease amygdala activity
and impair retention in the passive-avoidance procedure (Gallagher and Kapp, 1978;
Quirarte et al., 1998). Of course, before conclusions can be drawn with regard to the
involvement of specific brain sites in mediating the effect of swim stress on memory
modulation, local administration of adrenergic and opioid-receptor antagonists into the
brain, paralleling the systemic administration studies presented herein, are necessary.
Both adrenergic and opioid-receptor antagonists have been proposed as potential therapies
for posttraumatic stress disorder (Albucher and Liberzon, 2002; Pitman et al., 2002), a
disorder characterized by persistent and intrusive negative memories of a stressful event.
The present results support the efficacy of the two receptor antagonists in attenuating
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pathological memories but caution that their effectiveness may be stress-dependent and
enhanced by single, rather than simultaneous, administration.
In conclusion, the present results not only demonstrate the stress-dependent effects of
pharmacological blockade of the adrenergic and opioid systems on memory modulation, but
also provide a framework in which to view the protective role played by simultaneous
activation or inactivation of endogenous excitatory-adrenergic and inhibitory-opioid
modulation systems in mediating the effect of stress on memory.
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Fig. 1.
Propranolol impairs retention in the presence but not in the absence of swim stress. Step-
through latency (mean ± SEM) in seconds on the test trial for the No Swim-Vehicle group (n
= 8), No Swim-Pro group (n = 9), Swim-Vehicle group (n = 7), and Swim-Pro group (n = 9).
*p<0.05 compared with the corresponding vehicle group. P-values shown are for significant
protected-t tests following one-way ANOVA; F(3, 29) = 2.89, p = 0.05. Pro—propranolol
and Veh—vehicle.
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Fig. 2.
Propranolol and naloxone each impair retention in the presence of swim stress but not when
administered in combination. Step-through latency (mean ± SEM) in seconds on the test trial
for the Swim-Vehicle group (n = 8), Swim-Pro group (n = 10), Swim-Nal group (n = 10), and
Swim-Pro + Nal group (n = 8). *p<0.01 compared with the corresponding Swim-Vehicle
group and p<0.05 compared to the Swim-Pro + Nal group. P-values shown are for
significant protected-t tests following one-way ANOVA; F (3, 32) = 6.80, p<0.01. Pro—
propranolol, Nal—naloxone and Veh—vehicle.
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